A Severe Case of Drug-Induced Liver Injury after Gemcitabine Administration: A Highly Probable Causality Grading as Assessed by the Updated RUCAM Diagnostic Scoring System
Gemcitabine is an antineoplastic drug used in several forms of advanced pancreatic, lung, breast, ovarian, and bladder cancer. Common side effects include bone marrow suppression, fatigue, diarrhea, nausea, gastrointestinal upset, rash, alopecia, and stomatitis. Transient serum enzyme elevations cou...
Saved in:
Main Authors: | Ilenia Mascherona, Caterina Maggioli, Maira Biggiogero, Oreste Mora, Lucia Marelli |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2020-01-01
|
Series: | Case Reports in Hepatology |
Online Access: | http://dx.doi.org/10.1155/2020/8812983 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rifampicin for Treatment of Cholestatic Pruritus Caused by Drug-Induced Acute Liver Injury as Assessed by the RUCAM Classification
by: Ali R. Ahmadi, et al.
Published: (2020-01-01) -
The importance and development of carcass classification and grading in beef cattle: an update
by: Engin Sakarya, et al.
Published: (2020-06-01) -
The Role of Gemcitabine in the Treatment of Cholangiocarcinoma and Gallbladder Cancer: A Systematic Review
by: Brian H Dingle, et al.
Published: (2005-01-01) -
Establishment and characterization of three gemcitabine-resistant human intrahepatic cholangiocarcinoma cell lines
by: Jiandong Li, et al.
Published: (2025-02-01) -
Novel Approaches to Monitor Pharmacokinetics and Metabolism of Gemcitabine-Ibandronate Conjugate in Mice and Dogs
by: Jost Klawitter, et al.
Published: (2025-01-01)